CONMED CNMD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $13.83M+129% | $16.74M-50.4% | $2.86M-94.2% | $21.42M-28.5% | $6.04M-69.4% | ||
| $4.17M-1.4% | $4.07M-3.2% | $4.38M+4.3% | $4.47M+7.2% | $4.24M+4.7% | ||
| $5.5M-60.3% | $4.97M-20.1% | $4.59M-25.1% | $4.9M-29.7% | $13.86M+122% | ||
| $1.54M+158% | $812K-87.7% | $3.69M+46.3% | $1.68M+35.7% | -$2.66M-243% | ||
| $1.28M-11.6% | $1.54M+6.6% | $1.28M-11.6% | $1.39M-1.3% | $1.44M+2.6% | ||
| -$18.61M+2.0% | $22.67M+82.8% | -$9.16M+15.0% | $7.84M+957% | -$18.98M-2,191% | ||
| $12.27M+64.1% | —— | $2.22M-88.1% | $5.55M+644% | $7.48M+48.0% | ||
| $10.48M+243% | -$13.61M— | $5.48M+168% | —— | -$7.32M-156% | ||
| -$21.15M-159% | $5.92M— | $8.06M— | $9.11M— | -$8.18M+58.7% | ||
| $17.22M+218% | $225K-93.8% | $3.06M+13.0% | $4.45M+453% | $5.42M-20.0% | ||
| -$2.76M-127% | $6.61M+230% | $3.91M+2.0% | -$14.37M-30.9% | $10.05M+26.0% | ||
| —— | -$139.5K-189% | -$139.5K-189% | -$139.5K-189% | -$139.5K-189% | ||
| $722K-81.8% | $19.45M— | $1.34M+105% | -$1.8M+79.3% | $3.96M+161% | ||
| $13.47M-67.6% | $46.34M+6.9% | $53.69M+4.8% | $29.13M-32.7% | $41.53M+42.6% | ||
| $2.89M-23.5% | $5.11M+26.5% | $5.19M+51.7% | $5.73M+59.6% | $3.78M+85.7% | ||
| $0+100% | $2M— | —— | —— | -$850K— | ||
| $4.11M+240% | -$7.11M-76.0% | -$5.19M-51.7% | -$5.73M-59.6% | -$2.93M-43.9% | ||
| $0-100% | $6.19M+0.2% | $6.19M+0.4% | $6.19M+0.5% | $6.18M+0.4% | ||
| $37.02M— | —— | —— | —— | $0— | ||
| $180M+8.4% | $187M+24.7% | $167M+16.8% | $175.43M-14.0% | $166M-34.6% | ||
| $0-100% | $20M— | $25M— | $40.23M— | $14.59M— | ||
| $828K+278% | $4K-98.0% | $147K-92.6% | $483K-15.9% | -$464K-793% | ||
| -$22.55M+20.6% | -$37.37M+26.8% | -$43.53M-12.1% | -$26.53M+39.8% | -$28.4M-66.9% | ||
| -$814K-199% | $34K+102% | $20K— | $1.57M+355% | $819K+260% | ||
| -$5.79M-152% | $1.89M— | $4.99M-48.0% | $0— | $11.03M+15.3% | ||
| —— | $6.35M-22.2% | $6.35M-22.2% | $6.35M-22.2% | $6.35M-22.2% | ||
| $1.28M-11.6% | $1.54M+6.6% | $1.28M-11.6% | $1.39M-1.3% | $1.44M+2.6% | ||
| $722K-81.8% | $19.45M— | $1.34M+105% | -$1.8M+79.3% | $3.96M+161% | ||
| $4.17M-1.4% | $4.07M-3.2% | $4.38M+4.3% | $4.47M+7.2% | $4.24M+4.7% | ||
| -$3.92M— | —— | —— | —— | $0— | ||
| -$21.15M-159% | $5.92M— | $8.06M— | $9.11M— | -$8.18M+58.7% | ||
| $17.22M+218% | $225K-93.8% | $3.06M+13.0% | $4.45M+453% | $5.42M-20.0% | ||
| $14.66M+4.6% | $14.78M+7.1% | $14.23M+3.3% | $14.11M+3.2% | $14.02M+0.2% | ||
| $0+100% | $2M— | —— | —— | -$850K— | ||
| -$7M— | —— | —— | —— | $0— | ||
| $11.36M+58.6% | $11.18M+27.2% | $8.48M-2.0% | $6.93M-44.6% | $7.17M-73.4% | ||
| $828K+278% | $4K-98.0% | $147K-92.6% | $483K-15.9% | -$464K-793% | ||
| $0-100% | $20M— | $25M— | $40.23M— | $14.59M— | ||
| $10.58M-72.0% | $41.22M+4.9% | $48.5M+1.5% | $23.41M-41.1% | $37.76M+39.4% | ||
| $10.58M-72.0% | $41.22M+4.9% | $48.5M+1.5% | $23.41M-41.1% | $37.76M+39.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CONMED generate?
- CONMED (CNMD) generated $142.6M in operating cash flow over the trailing twelve months.
- What is CONMED's free cash flow?
- After $18.9M of capital expenditures, CONMED's free cash flow was $123.7M over the trailing twelve months, down 24.8% year over year.
- Where does CONMED's cash flow data come from?
- Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
